RPG LIFE SCIENCES LTD.

NSE : RPGLIFEBSE : 532983ISIN CODE : INE105J01010Industry : Pharmaceuticals & DrugsHouse : RPG Enterprises
BSE1567.5026.25 (+1.7 %)
PREV CLOSE ( ) 1541.25
OPEN PRICE ( ) 1551.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1274
TODAY'S LOW / HIGH ( )1544.70 1580.00
52 WK LOW / HIGH ( )745 1740
NSE1567.3018.55 (+1.2 %)
PREV CLOSE( ) 1548.75
OPEN PRICE ( ) 1552.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1567.30 (76)
VOLUME 22781
TODAY'S LOW / HIGH( ) 1550.00 1588.00
52 WK LOW / HIGH ( )748.6 1740
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2007
Management Info
Harsh Goenka - Chairman Yugal Sikri - Managing Director
Registered Office

Address R P G House , 463,Ceat Mahal,Dr. Annie Besant Road, Worli,
Mumbai,
Maharashtra-400030

Phone 022 - 24981650 / 24986375

Email info@rpglifesciences.com

Website www.rpglifesciences.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
12Mar RPG Life Sciences signs Share Subscrip
RPG Life Sciences has signed Share Subscription and Shareholders' agreem..
20Dec RPG Life Sciences informs about detail
RPG Life Sciences has enclosed intimation of the loss of share certifica..
19Oct RPG Life Sciences to execute power del
RPG Life Sciences has received approval for execution of Power Delivery..
19Oct RPG Life Sciences gains on geting nod
RPG Life Sciences is currently trading at Rs. 1426.00, up by 19.60 point..
19Oct RPG Life Sciences informs about invest
RPG Life Sciences has informed that it enclosed a copy of Investor Prese..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit264.6676.400000000001
Gross Profit 355.4 916.800000000001
Operating Profit 398.21074.9
Net Sales 15375128.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Divi's Lab (BSE)
 4025.35 (4.81%)
M.Cap (Rs. in Cr)106860.39
Sanofi India (BSE)
 8278.10 (1.76%)
M.Cap (Rs. in Cr)19064.98
Abbott India (BSE)
 25864.85 (0.54%)
M.Cap (Rs. in Cr)54961.00
Astrazeneca Pharma I (BSE)
 5415.40 (2.18%)
M.Cap (Rs. in Cr)13538.50
Glaxosmithkline Phar (BSE)
 2132.75 (3.26%)
M.Cap (Rs. in Cr)36130.07
Shareholding Pattern
PROMOTERS 72.81%
NON-INSTITUTION 24.13%
MUTUAL FUNDS/UTI 1.47%
FI/BANKS/INSURANCE 0.52%
GOVERNMENT 0%
FII 0%
Mf Holdings
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.